Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Cardiac Device Therapy in Patients with Chronic Kidney Disease – an Update

Version 1 : Received: 28 November 2023 / Approved: 13 December 2023 / Online: 13 December 2023 (10:19:04 CET)

A peer-reviewed article of this Preprint also exists.

Caba, B.; Vasiliu, L.; Covic, M.A.; Sascau, R.; Statescu, C.; Covic, A. Cardiac Device Therapy in Patients with Chronic Kidney Disease: An Update. J. Clin. Med. 2024, 13, 516. Caba, B.; Vasiliu, L.; Covic, M.A.; Sascau, R.; Statescu, C.; Covic, A. Cardiac Device Therapy in Patients with Chronic Kidney Disease: An Update. J. Clin. Med. 2024, 13, 516.

Abstract

Cardiovascular diseases (CVDs) and chronic kidney disease (CKD) are frequently interconnected and their association leads to an exponential increase in the risk of both fatal and non-fatal events. In addition, the burden of arrhythmias in CKD patients is increased. On the other hand, the presence of CKD is an important factor that influences the decision to pursue cardiac device therapy. Data on CKD patients with device therapy is scarce and mostly derives from observational studies and case reports. Cardiac resynchronization therapy (CRT) is associated with decreased mortality, reduced heart failure symptoms and improved renal function in early stages of CKD. Implantable cardioverter defibrillators (ICDs) are associated with a significant reduction in the mortality of CKD patients only for the secondary prevention of sudden cardiac death. Cardiac resynchronization therapy defibrillator (CRT-D) is preferred in patients that meet the established criteria. The need for cardiac pacing is 3-fold higher in dialysis patients. CKD is an independent risk factor for infections associated with cardiac devices.

Keywords

CKD; HF; CRT; LVAD; ICD; CIED; CRT-D; complications; mortality

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.